• Français

Centre de recherche
Thursday, March 31 2022
Press release

How risky is taking medications during pregnancy?

$2.4-million federal grant for Anick Bérard’s team

MONTREAL, March 31st, 2022 – Canadian university students and young researchers will have new tools to investigate the effects of taking medications during pregnancy thanks to a new $2.4-million federal grant to a team led by Anick Bérard, researcher at the CHU Sainte-Justine Research Centre and pharmacy professor at Université de Montréal.

The funding from the Canadian Institutes of Health Research will support the Canadian Mother-Child Collaborative Training Platform – CAMCCO-L, for short – a transdisciplinary and cross-sectoral training platform to better identify the risks and benefits of prescription drug use during pregnancy.

Announced by Canadian health minister Jean-Yves Duclos and mental-health and addictions minister Carolyn Bennett, the grant is part of $31.1-million in new federal funding to develop 13 health-research training platforms across the country over the next six years.

Lack of data to be overcome

Some 75 per cent of Canadian women take some form of medication during pregnancy. But there is little data on the associated risks and benefits for the mother and the unborn child, as pregnant women are often excluded from clinical trials of prescription drugs.

“To be able to effectively measure the risks and benefits requires cross-sectoral knowledge on epidemiology, genetics and toxicology, and the use of causal analysis methods and artificial intelligence,” said Bérard, holder of the Medication and Pregnancy Chair of the Fonds de recherche du Québec - Santé.

“Right now, however, training is based on courses designed for individual academic disciplines. The CAMCCO-L program offers the next generation of scientists something different and innovative: a new set of tools to study medications and pregnancy.”

Schools, a symposium and internships ahead

The new program will:

  • establish a virtual school offering perinatal-related courses in toxicology, pharmacogenomics, pharmacoepidemiology and artificial intelligence;
  • establish a summer school on drug development and knowledge transfer;
  • fund an annual symposium for the next generation of independent Canadian researchers in perinatality;
  • and provide an opportunity for participants to complete four-month internships in research environments in addtion to their university training.

As well as teaching graduate students and early-career researchers practical skills such as project management and grant-writing, the platform also emphasizes the principles of equity, diversity and inclusion, including offering scholarships for students and researchers from First Nations communities.
 

– 30 –

Who is involved in CAMCCO-L

The Canadian Mother-Child Collaborative Training Platform involves many institutional collaborators and partners. Among Canadian universities, they include McGill, Queen’s, Dalhousie and Université du Québec en Abitibi-Témiscamingue, as well as the universities of Ottawa, Manitoba, Saskatchewan, Alberta and British Colombia. Foreign academic partners include Australian National University and the universities of Barcelona, São Paulo and Paul-Sabatier de Toulouse. CAMCCO-L’s non-university collaborators include Health Canada, the Maternal Infant Child and Youth Research Network (MICYRN), the Society of Obstetricians and Gynaecologists of Canada (SOGC), the Maternal-Fetal Specialists of Quebec, Médicament Québec, Mitacs and the U.S. health-technology giant IQVIA.

About the CHU Sainte-Justine Research Centre 

The CHU Sainte-Justine Research Centre is a leading mother-child research institution affiliated with the Université de Montréal. It brings together more than 210 research investigators, including over 110 clinician-scientists, as well as 450 graduate and postgraduate students focused on finding innovative prevention means, faster and less invasive treatments, as well as personalized approaches to medicine. The centre is part of CHU Sainte-Justine, which is the largest mother-child centre in Canada. 
recherche.chusj.org
@CR_CHUSJ

Media resource person:

Lucie Dufresne
Assistant Director of Communication
CHU Sainte-Justine
514 - 345-4931 ext 7707
lucie.dufresne.hsj@ssss.gouv.qc.ca 

 

 

About this page
Updated on 9/28/2022
Created on 3/31/2022
Alert or send a suggestion
 

Grow Beyond our wildest dreams

With the support of donors like you, at the heart of the Grow Beyond campaign, we are leading healthcare teams towards the opportunities offered by science and new technologies, so that every child, no matter where in Quebec, has access to the unique expertise and know-how of CHU Sainte-Justine. Together, let's join forces for their future.

Grow Beyond with us.

Contact Us

514 345-4931

Legal

© 2006-2014 CHU Sainte-Justine.
All rights reserved. 
Terms of Use,  Confidentiality,  Security

Warning

All information contained within the CHU Sainte-Justine site should not be used as a substitute for the advice of a duly qualified and authorized medical practitioner or any other health professional. The information provided on this site is intended for educational and informational purposes only.

Consult your physician if you feel ill or call 911 for any medical emergency.

CHU Sainte-Justine